CIK: 0001442276
Total reported value
$13.9M
Reporting period: 2019-12-31 · Number of holdings: 41
Partner Investment Management, L.P. disclosed 41 holdings in its latest 13F filing for the period ending 2019-12-31, with total reported value of $13.9M and a quarterly turnover rate of 146.9%.
Browse other institutions with under $100M AUMBrowse other institutions starting with "P"
Partner Investment Management, L.P.'s disclosed holdings carry a Herfindahl concentration index of 0.037 — mathematically equivalent to about 27 equally-sized positions, close to its 41 actual disclosed holdings. Value is spread relatively evenly across the portfolio rather than concentrated in a handful of names.
Position sizes are fairly uniform across the portfolio (a coefficient of variation of 0.72), suggesting a disciplined, rules-based approach to how much capital goes into each idea.
No strong tilt toward either adding to existing winners or initiating outsized new positions was observed in the latest reported quarter.
Sector classification currently covers about 22% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Add BOLDEUR
-29.9% $352.0K
Add ALNAEUR
0.0% -$344.0K
Add ALXN
-62.0% -$1.3M
Add GILD
-61.8% -$1.1M
Add PEN
-70.5% -$1.1M
Add CI
-68.9% -$630.0K
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | BOLDEUR | Audentes Therapeutics INC | Stock-Other | 7.65% | +6.43% | -29.86% | |
| 2 | ALXN | Alexion Pharmaceuticals INC | Stock-Other | 6.54% | +2.83% | -61.96% | |
| 3 | ALNAEUR | Allena Pharmaceuticals INC | Stock-Other | 5.57% | +3.65% | — | |
| 4 | GILD | Gilead Sciences INC | Stock-Healthcare | 5.08% | +1.99% | -61.76% | |
| 5 | PEN | Penumbra INC | Stock-Healthcare | 4.37% | +1.48% | -70.54% | |
| 6 | ZBH | Zimmer Biomet Holdings INC | Stock-Healthcare | 3.96% | -0.20% | -79.14% | |
| 7 | BIIB | Biogen INC | Stock-Healthcare | 3.92% | +3.92% | NEW | |
| 8 | NVROEUR | Nevro CORP | Stock-Other | 3.81% | — | -21.71% | |
| 9 | ELV | Elevance Health INC | Stock-Healthcare | 3.62% | +3.62% | NEW | |
| 10 | HUM | Humana INC | Stock-Healthcare | 3.55% | +3.55% | NEW | |
| 11 | CI | THE Cigna Group | Stock-Healthcare | 3.25% | +1.40% | -68.93% | |
| 12 | IQV | Iqvia Holdings INC | Stock-Healthcare | 3.25% | +1.06% | -65.85% | |
| 13 | BMRN | Biomarin Pharmaceutical INC | Stock-Healthcare | 3.24% | -0.15% | -81.84% | |
| 14 | ✓ | Stock-Other | 3.13% | +1.01% | -69.05% | ||
| 15 | AERIEUR | Aerie Pharmaceuticals INC | Stock-Other | 3.13% | — | +7.79% | |
| 16 | ARNAEUR | Arena Pharmaceuticals INC | Stock-Other | 3.09% | +0.83% | -67.16% | |
| 17 | CNC | Centene CORP | Stock-Healthcare | 3.09% | +3.09% | NEW | |
| 18 | NVS | Novartis Ag-sponsored Adr | Stock-Healthcare | 2.81% | +1.22% | -60.13% | |
| 19 | HCA | Hca Healthcare INC | Stock-Healthcare | 2.48% | +0.93% | -68.87% | |
| 20 | PFE | Pfizer INC | Stock-Healthcare | 2.11% | — | — | |
| 21 | ICUI | Icu Medical INC | Stock-Other | 1.85% | — | — | |
| 22 | DERMEUR | Dermira INC | Stock-Other | 1.84% | — | -43.69% | |
| 23 | ICLR | ICON Public Limited Company | Stock-Healthcare | 1.73% | — | -56.35% | |
| 24 | UNH | Unitedhealth Group INC | Stock-Healthcare | 1.67% | — | — | |
| 25 | IRTC | Irhythm Holdings INC | Stock-Healthcare | 1.66% | +0.04% | -73.44% | |
| 26 | IMMU | Immunomedics INC | Stock-Other | 1.65% | — | — | |
| 27 | ABT | Abbott Laboratories | Stock-Healthcare | 1.60% | — | — | |
| 28 | MOH | Molina Healthcare INC | Stock-Healthcare | 1.35% | — | -80.69% | |
| 29 | EW | Edwards Lifesciences CORP | Stock-Healthcare | 1.32% | -0.08% | -78.81% | |
| 30 | LAB | Standard Biotools INC | Stock-Other | 0.95% | — | +7.08% | |
| 31 | ✓ | Morphosys | Stock-Other | 0.90% | — | — | |
| 32 | CTLTEUR | Catalent INC | Stock-Other | 0.90% | -0.21% | -83.55% | |
| 33 | ABBV | Abbvie INC | Stock-Healthcare | 0.80% | — | — | |
| 34 | AXNX* | Axonics INC | Stock-Other | 0.79% | — | +105.37% | |
| 35 | CSIIEUR | Cardiovascular Systems INC | Stock-Other | 0.69% | — | -66.44% | |
| 36 | VRTX | Vertex Pharmaceuticals INC | Stock-Healthcare | 0.68% | — | — | |
| 37 | HALO | Halozyme Therapeutics INC | Stock-Healthcare | 0.59% | — | — | |
| 38 | ✓ | Amarin Corp PLC | Stock-Other | 0.58% | — | — | |
| 39 | CHRS | Coherus Oncology INC | Stock-Other | 0.49% | — | -51.69% | |
| 40 | ✓ | Acorda Therapeutics INC | Stock-Other | 0.27% | — | -7.73% | |
| 41 | ELGXEUR | Endologix INC | Stock-Other | 0.03% | — | -15.34% |
Not enough priced holdings yet to compute performance
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2019-12-31 | 41 | $13.9M | 100 | |
| 2019-09-30 | 69 | $58.4M | 100 | |
| 2019-06-30 | 81 | $94.2M | 81 | |
| 2019-03-31 | 90 | $86.5M | 98 | |
| 2018-12-31 | 88 | $80.1M | 91 | |
| 2018-09-30 | 113 | $130.6M | 68 | |
| 2018-06-30 | 115 | $123.8M | 74 | |
| 2018-03-31 | 88 | $92.6M | 77 | |
| 2017-12-31 | 75 | $86.8M | 78 | |
| 2017-09-30 | 84 | $105.4M | 88 | |
| 2017-06-30 | 86 | $74.4M | 100 | |
| 2017-03-31 | 96 | $82.1M | 100 | |
| 2016-12-31 | 90 | $75.5M | 96 | |
| 2016-09-30 | 84 | $67.5M | 100 | |
| 2016-06-30 | 79 | $61.1M | 100 | |
| 2016-03-31 | 79 | $61.4M | 95 | |
| 2015-12-31 | 64 | $61.0M | 86 | |
| 2015-09-30 | 71 | $66.2M | 77 | |
| 2015-06-30 | 86 | $71.1M | 89 | |
| 2015-03-31 | 82 | $66.4M | 100 | |
| 2014-12-31 | 89 | $245.1M | 100 | |
| 2014-09-30 | 64 | $273.6M | 76 | |
| 2014-06-30 | 64 | $499.4M | 98 | |
| 2014-03-31 | 72 | $542.2M | 100 | |
| 2013-12-31 | 60 | $440.7M | 96 | |
| 2013-09-30 | 73 | $375.4M | 82 | |
| 2013-06-30 | 76 | $441.9M | 0 |
Partner Investment Management, L.P.'s most significant position changes for 2019-12-31: Sold out: Novo-Nordisk A-S Ord; Sold out: NXP Semiconductors N.V. (NXPI); Sold out: Microchip Technology INC (MCHP); Sold out: Twilio INC - A (TWLO); Sold out: Western Digital CORP (WDC).
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | BOLDEUR | Audentes Therapeutics INC | +6.4% | -29.86% | Trim |
| 2 | ALNAEUR | Allena Pharmaceuticals INC | +3.7% | — | Unchanged |
| 3 | ALXN | Alexion Pharmaceuticals INC | +2.8% | -61.96% | Trim |
| 4 | GILD | Gilead Sciences INC | +2% | -61.76% | Trim |
| 5 | PEN | Penumbra INC | +1.5% | -70.54% | Trim |
| 6 | CI | THE Cigna Group | +1.4% | -68.93% | Trim |
| 7 | NVS | Novartis Ag-sponsored Adr | +1.2% | -60.13% | Trim |
| 8 | IQV | Iqvia Holdings INC | +1.1% | -65.85% | Trim |
| 9 | ✓ | +1% | -69.05% | Trim | |
| 10 | HCA | Hca Healthcare INC | +0.9% | -68.87% | Trim |
| 11 | ARNAEUR | Arena Pharmaceuticals INC | +0.8% | -67.16% | Trim |
| 12 | IRTC | Irhythm Holdings INC | 0% | -73.44% | Trim |
| 13 | MOH | Molina Healthcare INC | — | -80.69% | Trim |
| 14 | EW | Edwards Lifesciences CORP | -0.1% | -78.81% | Trim |
| 15 | BMRN | Biomarin Pharmaceutical INC | -0.2% | -81.84% | Trim |
| 16 | ZBH | Zimmer Biomet Holdings INC | -0.2% | -79.14% | Trim |
| 17 | CTLTEUR | Catalent INC | -0.2% | -83.55% | Trim |
| 18 | ✓ | Novo-Nordisk A-S Ord | — | EXIT | Sold out |
| 19 | NXPI | NXP Semiconductors N.V. | — | EXIT | Sold out |
| 20 | MCHP | Microchip Technology INC | — | EXIT | Sold out |
| 21 | TWLO | Twilio INC - A | — | EXIT | Sold out |
| 22 | WDC | Western Digital CORP | — | EXIT | Sold out |
| 23 | INTU | Intuit INC | — | EXIT | Sold out |
| 24 | CRM | Salesforce INC | — | EXIT | Sold out |
| 25 | GDDY | Godaddy INC - Class A | — | EXIT | Sold out |
| 26 | XBI | Ss Spdr S&p Biotech ETF | — | EXIT | Sold out |
| 27 | WCGEUR | Wellcare Health Plans INC | — | EXIT | Sold out |
| 28 | MSFT | Microsoft CORP | — | EXIT | Sold out |
| 29 | SYK | Stryker CORP | — | EXIT | Sold out |
| 30 | MKSI | Mks INC | — | EXIT | Sold out |
| 31 | DXCM | Dexcom INC | — | EXIT | Sold out |
| 32 | MYOKEUR | Myokardia INC | — | EXIT | Sold out |
| 33 | V | Visa Inc-class A Shares | — | EXIT | Sold out |
| 34 | AMD | Advanced Micro Devices | — | EXIT | Sold out |
| 35 | PTCT | Ptc Therapeutics INC | — | EXIT | Sold out |
| 36 | TWTRUSD | Twitter INC | — | EXIT | Sold out |
| 37 | COUPEUR | Coupa Software INC | — | EXIT | Sold out |
| 38 | SG7 | Sage Therapeutics INC | — | EXIT | Sold out |
| 39 | QURE | uniQure N.V. | — | EXIT | Sold out |
| 40 | BIIB | Biogen INC | — | NEW | New buy |
| 41 | ACOR 1.75 06-15-21 | Acorda Therapeutics INC | — | EXIT | Sold out |
| 42 | ELV | Elevance Health INC | — | NEW | New buy |
| 43 | HUM | Humana INC | — | NEW | New buy |
| 44 | LYV | Live Nation Entertainment In | — | EXIT | Sold out |
| 45 | CNC | Centene CORP | — | NEW | New buy |
| 46 | BABA | Alibaba Group Holding-sp Adr | — | EXIT | Sold out |
| 47 | MRTXEUR | Mirati Therapeutics INC | — | EXIT | Sold out |
| 48 | VC | Visteon CORP | — | EXIT | Sold out |
| 49 | MCK | Mckesson CORP | — | EXIT | Sold out |
| 50 | PBYI | Puma Biotechnology INC | — | EXIT | Sold out |
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2019-12-31 | 2020-02-14 | 13F-HR | View on EDGAR |
| 2019-09-30 | 2019-11-14 | 13F-HR | View on EDGAR |
| 2019-06-30 | 2019-08-14 | 13F-HR | View on EDGAR |
| 2019-03-31 | 2019-05-15 | 13F-HR | View on EDGAR |
| 2018-12-31 | 2019-02-14 | 13F-HR | View on EDGAR |
| 2018-09-30 | 2018-11-13 | 13F-HR | View on EDGAR |
| 2018-06-30 | 2018-08-14 | 13F-HR | View on EDGAR |
| 2018-03-31 | 2018-05-15 | 13F-HR | View on EDGAR |
| 2017-12-31 | 2018-02-14 | 13F-HR | View on EDGAR |
| 2017-09-30 | 2017-11-14 | 13F-HR | View on EDGAR |
| 2017-06-30 | 2017-08-14 | 13F-HR | View on EDGAR |
| 2017-03-31 | 2017-05-15 | 13F-HR | View on EDGAR |
| 2016-12-31 | 2017-02-14 | 13F-HR | View on EDGAR |
| 2016-09-30 | 2016-11-14 | 13F-HR | View on EDGAR |
| 2016-06-30 | 2016-08-15 | 13F-HR | View on EDGAR |
| 2016-03-31 | 2016-05-16 | 13F-HR | View on EDGAR |
| 2015-12-31 | 2016-02-16 | 13F-HR | View on EDGAR |
| 2015-09-30 | 2015-11-16 | 13F-HR | View on EDGAR |
| 2015-06-30 | 2015-08-14 | 13F-HR | View on EDGAR |
| 2015-03-31 | 2015-05-15 | 13F-HR | View on EDGAR |
| 2014-12-31 | 2015-02-17 | 13F-HR | View on EDGAR |
| 2014-09-30 | 2014-11-14 | 13F-HR | View on EDGAR |
| 2014-06-30 | 2014-08-14 | 13F-HR | View on EDGAR |
| 2014-03-31 | 2014-05-15 | 13F-HR | View on EDGAR |
| 2013-12-31 | 2014-02-21 | Amendment | View on EDGAR |
| 2013-12-31 | 2014-02-14 | 13F-HR | View on EDGAR |
| 2013-09-30 | 2014-02-21 | Amendment | View on EDGAR |
| 2013-09-30 | 2013-11-14 | 13F-HR | View on EDGAR |
| 2013-06-30 | 2014-02-21 | Amendment | View on EDGAR |
| 2013-06-30 | 2013-08-14 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0001668343
Total reported value
$13.9M
2 stks
2026-03-31
AUM within 0.4% of this institution
CIK 0001385426
Total reported value
$14.0M
1 stks
2021-09-30
Stale — no recent filing
AUM within 0.6% of this institution
CIK 0001726104
Total reported value
$14.0M
6 stks
2021-03-31
Stale — no recent filing
AUM within 0.7% of this institution
Institutions with overlapping top holdings
CIK 0000019481
Total reported value
$362.5M
450 stks
2026-03-31
1 of the top 5 holdings overlap, including Gilead Sciences INC
CIK 0000275216
Total reported value
$11.6B
1,648 stks
2015-09-30
Stale — no recent filing
1 of the top 5 holdings overlap, including Gilead Sciences INC
CIK 0000716187
Total reported value
$699.0M
7 stks
2019-06-30
Stale — no recent filing
1 of the top 5 holdings overlap, including Gilead Sciences INC